ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 50 filers reported holding ARCELLX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,071,628 | +37.6% | 29,867 | +21.2% | 0.00% | – |
Q2 2023 | $779,024 | +253.5% | 24,637 | +244.4% | 0.00% | – |
Q1 2023 | $220,384 | +6.7% | 7,153 | +7.3% | 0.00% | – |
Q4 2022 | $206,451 | +297.0% | 6,664 | +141.5% | 0.00% | – |
Q3 2022 | $52,000 | +225.0% | 2,759 | +209.3% | 0.00% | – |
Q2 2022 | $16,000 | +33.3% | 892 | +5.8% | 0.00% | – |
Q1 2022 | $12,000 | – | 843 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |